Advantage Alpha Capital Partners LP Veracyte, Inc. Transaction History
Advantage Alpha Capital Partners LP
- $387 Million
- Q4 2024
A detailed history of Advantage Alpha Capital Partners LP transactions in Veracyte, Inc. stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 17,129 shares of VCYT stock, worth $573,136. This represents 0.18% of its overall portfolio holdings.
Number of Shares
17,129
Previous 25,066
31.66%
Holding current value
$573,136
Previous $852,000
20.42%
% of portfolio
0.18%
Previous 0.2%
Shares
5 transactions
Others Institutions Holding VCYT
# of Institutions
337Shares Held
80.2MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$275 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$261 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$221 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$141 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$137 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.39B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...